(19)
(11) EP 4 103 180 A1

(12)

(43) Date of publication:
21.12.2022 Bulletin 2022/51

(21) Application number: 21754211.7

(22) Date of filing: 09.02.2021
(51) International Patent Classification (IPC): 
A61K 31/4745(2006.01)
A61K 45/06(2006.01)
 A61K 31/337(2006.01)
A61P 35/00(2006.01)
(52) Cooperative Patent Classification (CPC):
A61K 31/4745; A61K 31/337; A61P 35/00; A61K 45/06
 
C-Sets:
  1. A61K 31/337, A61K 2300/00;
  2. A61K 31/4745, A61K 2300/00;
(86) International application number:
PCT/US2021/017259
(87) International publication number:
WO 2021/163058 (19.08.2021 Gazette 2021/33)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(30) Priority: 10.02.2020 US 202062972442 P

(71) Applicant: Corcept Therapeutics Incorporated
Menlo Park, CA 94025 (US)

(72) Inventors:
  • GREENSTEIN, Andrew E.
    Menlo Park, California 94025 (US)
  • GRAUER, Andreas
    Menlo Park, California 94025 (US)
  • SHEPHERD, Stacie Peacock
    Menlo Park, California 94025 (US)

(74) Representative: Geling, Andrea 
ZSP Patentanwälte PartG mbB Hansastraße 32
80686 München
80686 München (DE)

   


(54) METHODS OF STIMULATING AN ANTI-TUMOR RESPONSE USING A SELECTIVE GLUCOCORTICOID RECEPTOR MODULATOR